Sarepta Therapeutics (SRPT) Net Margin Growth (1y) (2011 - 2026)

Sarepta Therapeutics (SRPT) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Sarepta Therapeutics 1.69 Bn 1.28 Bn 622.04 Mn 38,093.00

Historic Data

Download Data
DateValue
Mar 31, 2026 38,093.00
Dec 31, 2025 -8,798.00
Sep 30, 2025 -5,225.00
Jun 30, 2025 3,035.00
Mar 31, 2025 -34,448.00
Dec 31, 2024 1,990.00
Sep 30, 2024 2,043.00
Jun 30, 2024 1,104.00
Mar 31, 2024 23,206.00
Dec 31, 2023 -3,380.00
Sep 30, 2023 9,869.00
Jun 30, 2023 10,042.00
Mar 31, 2023 -16,760.00
Dec 31, 2022 10,644.00
Sep 30, 2022 10,209.00
Jun 30, 2022 -5,997.00
Mar 31, 2022 5,820.00
Dec 31, 2021 6,202.00
Sep 30, 2021 -5,220.00
Jun 30, 2021 6,019.00